Clinical Trials Update: March 3, 2011 (HealthDay)

HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:

Labeling change for antipsychotic drugs highlights risk to newborns

FDA has updated the pregnancy section of drug labels for the entire class of antipsychotic medications to provide more information about the potential risk of extrapyramidal signs and withdrawal symptoms in newborns whose mothers take antipsychotics during the third trimester of pregnancy.

Black box warnings accelerate reduced antipsychotic use in dementia

The rate of decline in the use of atypical antipsychotics in outpatients with dementia accelerated following a black box warning issued by FDA, according to "Trends in Antipsychotic Use in Dementia 1999-2007," a multicenter study of national Veterans Affairs data that appeared in the Archives of General Psychiatry.

Two drugs show promise in advanced pancreatic neuroendocrine tumors

Sunitinib and everolimus improved progression-free survival in patients with advanced pancreatic neuroendocrine tumors, according to 2 recent studies published in the New England Journal of Medicine.

Black-box warnings accelerate reduced antipsychotic use in dementia

The rate of decline in the use of atypical antipsychotics in outpatients with dementia accelerated following a black-box warning issued by FDA, according to "Trends in Antipsychotic Use in Dementia 1999-2007," a multicenter study of national Veterans Affairs data that appeared in the Archives of General Psychiatry.

TXA reduces death from bleeding in trauma patients

Tranexamic acid reduces the risk of death from bleeding without increasing the risk of vascular occlusive events or the need for surgical intervention, according to a review published in the 2011 Cochrane Database of Systematic Reviews.

Clinical Trials Update: March 2, 2011 (HealthDay)

HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:

FDA Bans Unapproved Prescription Cough, Cold and Allergy Meds (HealthDay)

HealthDay - WEDNESDAY, March 2 (HealthDay News) -- The U.S. Food and Drug Administration said Wednesday that it plans to remove about 500 unapproved prescription cough, cold, and allergy medicines from pharmacy shelves.

Expanding Medicaid will cost states billions: study (Reuters)

Reuters - The costs to U.S. states of the Medicaid insurance program for the poor will grow by hundreds of billions of dollars under the healthcare law passed last year, according to a report released by Republicans in the Senate and House of Representatives on Tuesday.

Clinical Trials Update: March 2, 2011 (HealthDay)

HealthDay - (HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:

« Previous Page — Next Page »